Avant Brands (AVNT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
15 Jul, 2026Executive summary
Operates four licensed indoor cannabis cultivation facilities with approximately 180 employees and over $41 million in annual sales for F2025.
Recognized as a top innovator and premium brand in the Canadian cannabis sector, with multiple industry awards and a strong focus on quality and genetics.
Achieved 34% year-to-date growth in recreational revenue, with leading market share for BLK MKT and Tenzo brands in Ontario.
Distribution spans domestic recreational, medical, B2B, and international export channels, with rapid growth in export markets such as Israel, Australia, and Germany.
Nearly 90% reduction in total outstanding debt over 24 months, from $8.1 million to $1.03 million.
Financial highlights
F2025 gross sales reached $41.3M, up 3% year-over-year; net sales were $35.9M.
For the six months ended May 31, 2026, sales totaled $9.2M, with YTD net cash flows from operating activities of $1.7M.
Q2 2026 gross revenue: $9.2M (-5% year-over-year); net revenue: $7.8M (-8%).
Gross margin for F2025 was $7.7M, following a peak of $16.2M in F2024.
Cash balance increased to $3.3M as of May 31, 2026, from $1.5M at fiscal 2025 year-end.
Outlook and guidance
Export is the fastest-growing sales channel, showing high double-digit annual growth.
Infrastructure upgrades at Flowr expected to reduce electrical demand, increase facility capacity, and enhance product quality.
Actively pursuing expansion into additional provincial and territorial markets domestically.
Continued focus on optimizing SKU portfolio and scaling high-demand products to support long-term revenue growth.
Ongoing strategy to further reduce corporate debt and strengthen the balance sheet.
Latest events from Avant Brands
- Premium cannabis producer with strong sales growth, global reach, and award-winning brands.AVNT
Investor presentation - Sixth consecutive positive Adjusted EBITDA and 11% export revenue growth highlight Q2 2025.AVNT
Q2 2025 - Premium cannabis producer with strong sales, innovation, and rapid export growth.AVNT
Investor presentation - Recreational sales surged 37% while export declines and upgrades weighed on Q1 profit.AVNT
Q1 2026 - Premium cannabis producer with strong export markets and certified indoor facilities.AVNT
Investor presentation - Gross sales hit $41.3M, recreational revenue up 19%, and net loss down 56% in F2025.AVNT
Q4 2025 - Revenue and cash flow rose sharply, with domestic wholesale up 307% and EBITDA positive again.AVNT
Q3 2025 - Record Q3 revenue and export growth highlight Avant's accelerating global cannabis expansion.AVNT
Q3 2024 - Record Q2 revenue and profitability driven by surging international cannabis sales.AVNT
Q2 2024